bpc-157 clinical trial nct02637284 A human was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled trial (NCT02637284) was launched Stable Gastric Pentadecapeptide BPC 157
Description
The proposed biology includes follicle signaling, reduced inflammation around follicles, and scalp conditions that make a growth phase easier to sustain
Review Score : Target a minimum supplier review score of 4.5 or higher for reliability
[48] What the nursing mother consumes is more important than her liver tissue content, as it is recently absorbed vitamin that more effectively reaches breast milk
Retrieved 17 January 2008
BPC-157 isn't FDA-approved for any indication
